Search Results - "Couselo EM"

Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma.

Authors: Dummer R Sandhu S Miller WH Jr et al.

Source: Future oncology (London, England) [Future Oncol] 2026 Apr; Vol. 22 (9), pp. 995-1013. Date of Electronic Publication: 2026 Mar 31.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE; In Process

Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab.

Authors: Gogas H Ravimohan S Datta A et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2024 Jul 19; Vol. 8 (1), pp. 150. Date of Electronic Publication: 2024 Jul 19.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposure.

Authors: Spreafico A Couselo EM Irmisch A et al.

Source: Frontiers in oncology [Front Oncol] 2024 Mar 21; Vol. 14, pp. 1346502. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study.

Authors: Mandalà M Amaral T Rutkowski P et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Jul 25; Vol. 225, pp. 115567. Date of Electronic Publication: 2025 Jun 09.

Publication Type: Comparative Study; Journal Article; Multicenter Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research.

Authors: Amaral T Nanz L Higuita LMS et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Jan 17; Vol. 215, pp. 115160. Date of Electronic Publication: 2024 Dec 13.

Publication Type: Journal Article; Systematic Review; Comparative Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.

Authors: Mandalà M Lorigan P Sergi MC et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Mar; Vol. 199, pp. 113542. Date of Electronic Publication: 2024 Jan 19.

Publication Type: Multicenter Study; Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy.

Authors: Weiss SA Sznol M Shaheen M et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jan 05; Vol. 30 (1), pp. 74-81.

Publication Type: Clinical Trial, Phase II; Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart review.

Authors: Mohr P Kiecker F Soriano V et al.

Source: Melanoma management [Melanoma Manag] 2019 Oct 04; Vol. 6 (4), pp. MMT33. Date of Electronic Publication: 2019 Oct 04.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101649842 Publication Model: Electronic Cited Medium: Print ISSN: 2045-0885 (Print) Linking ISSN: 20450885 NLM ISO Abbreviation: Melanoma Manag Subsets: PubMed not MEDLINE